Gioia Colafigli | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Overall Survival and Response Rates after a 10-Year Follow-up of Chronic Myeloid Leukemia Patients in Chronic Phase Treated with Imatinib in a Real-Life Practice	BLOOD	2018
Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients	AMERICAN JOURNAL OF HEMATOLOGY	2017
Long-term impact of molecular response fluctuations in chronic myeloid leukaemia patients treated with imatinib.	BRITISH JOURNAL OF HAEMATOLOGY	2017
Body mass index does not impact on molecular response rate of chronic myeloid leukaemia patients treated frontline with second generation tyrosine kinase inhibitors.	BRITISH JOURNAL OF HAEMATOLOGY	2017
Clinical relevance of silent red blood cell autoantibodies.	HAEMATOLOGICA	2017
Independent prognostic impact of CD15 on complete remission achievement in patients with acute myeloid leukemia	HEMATOLOGICAL ONCOLOGY	2017
Ruxolitinib in clinical practice for primary and secondary myelofibrosis: an analysis of safety and efficacy of Gruppo Laziale of Ph-negative MPN.	ANNALS OF HEMATOLOGY	2017
The Eutos long-term survival score accurately predicts the risk of death in chronic myeloid leukaemia patients treated outside of clinical trials.	AMERICAN JOURNAL OF HEMATOLOGY	2017
Timing and deepness of response to tyrosine kinase inhibitors as a measure of potential treatment discontinuation in chronic myeloid leukemia patients managed in the real-life	AMERICAN JOURNAL OF HEMATOLOGY	2017
The Eutos long-term survival score accurately predicts the risk of death in chronic myeloid leukaemia patients treated outside of clinical trials	AMERICAN JOURNAL OF HEMATOLOGY	2017
Clinical characteristics and outcome of patients with autoimmune hemolytic anemia (AIHA) uniformly defined as primary by a diagnostic work-up	AMERICAN JOURNAL OF HEMATOLOGY	2016
Sex correlates with differences in long-term outcome in chronic myeloid leukaemia patients treated with imatinib	BRITISH JOURNAL OF HAEMATOLOGY	2015
Improvement of bone marrow fibrosis with ruxolitinib: will this finding change our perception of the drug?	EXPERT REVIEW OF HEMATOLOGY	2015
Correlation between Charlson comorbidity index and outcome in patients with chronic phase chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors upfront	LEUKEMIA & LYMPHOMA	2015